IMbrave150: updated efficacy and safety by risk status in patients (pts) receiving atezolizumab (atezo) + bevacizumab (bev) vs sorafenib (sor) as first-lin... Background Ph 1b data has shown promising efficacy and safety for atezo + bev in unresectable HCC pts who have not received prior...
Patients under consideration for this treatment regimen should undergo upper endoscopy with the appropriate management before initiation, and those with high risk of bleeding should be excluded, Harris concludes.Related Videos Dr Mekhail on a Case Study of Early-Stage, Nonmetastatic Lung Cancer Dr ...
7University Medical Centre Mainz, Mainz, Germany Abstract: A virtual expert roundtable was convened on April 16, 2020, to discuss the evolving landscape of care for treating patients with advanced hepatocellular carcinoma (HCC) and discuss questions related to patient care and treatment selection. ...